159 related articles for article (PubMed ID: 17019713)
1. Ursodeoxycholic acid modulates histone acetylation and induces differentiation and senescence.
Akare S; Jean-Louis S; Chen W; Wood DJ; Powell AA; Martinez JD
Int J Cancer; 2006 Dec; 119(12):2958-69. PubMed ID: 17019713
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth.
Kim EK; Cho JH; Kim E; Kim YJ
PLoS One; 2017; 12(7):e0181183. PubMed ID: 28708871
[TBL] [Abstract][Full Text] [Related]
3. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.
Hinnebusch BF; Meng S; Wu JT; Archer SY; Hodin RA
J Nutr; 2002 May; 132(5):1012-7. PubMed ID: 11983830
[TBL] [Abstract][Full Text] [Related]
4. The chemopreventive agent ursodeoxycholic acid inhibits proliferation of colon carcinoma cells by suppressing c-Myc expression.
Peiró-Jordán R; Krishna-Subramanian S; Hanski ML; Lüscher-Firzlaff J; Zeitz M; Hanski C
Eur J Cancer Prev; 2012 Sep; 21(5):413-22. PubMed ID: 22395148
[TBL] [Abstract][Full Text] [Related]
5. Regulation of replicative and stress-induced senescence by RSK4, which is down-regulated in human tumors.
López-Vicente L; Armengol G; Pons B; Coch L; Argelaguet E; Lleonart M; Hernández-Losa J; de Torres I; Ramon y Cajal S
Clin Cancer Res; 2009 Jul; 15(14):4546-53. PubMed ID: 19584160
[TBL] [Abstract][Full Text] [Related]
6. Differential apoptosis by gallotannin in human colon cancer cells with distinct p53 status.
Al-Ayyoubi S; Gali-Muhtasib H
Mol Carcinog; 2007 Mar; 46(3):176-86. PubMed ID: 17192871
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
[TBL] [Abstract][Full Text] [Related]
8. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
Chen YX; Fang JY; Lu J; Qiu DK
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
[TBL] [Abstract][Full Text] [Related]
9. Premature senescence in human breast cancer and colon cancer cells by tamoxifen-mediated reactive oxygen species generation.
Lee YH; Kang BS; Bae YS
Life Sci; 2014 Mar; 97(2):116-22. PubMed ID: 24361399
[TBL] [Abstract][Full Text] [Related]
10. Repression of HIP/RPL29 expression induces differentiation in colon cancer cells.
Liu JJ; Huang BH; Zhang J; Carson DD; Hooi SC
J Cell Physiol; 2006 May; 207(2):287-92. PubMed ID: 16475173
[TBL] [Abstract][Full Text] [Related]
11. MLN8054, an inhibitor of Aurora A kinase, induces senescence in human tumor cells both in vitro and in vivo.
Huck JJ; Zhang M; McDonald A; Bowman D; Hoar KM; Stringer B; Ecsedy J; Manfredi MG; Hyer ML
Mol Cancer Res; 2010 Mar; 8(3):373-84. PubMed ID: 20197380
[TBL] [Abstract][Full Text] [Related]
12. Transient vs. prolonged histone hyperacetylation: effects on colon cancer cell growth, differentiation, and apoptosis.
Wu JT; Archer SY; Hinnebusch B; Meng S; Hodin RA
Am J Physiol Gastrointest Liver Physiol; 2001 Mar; 280(3):G482-90. PubMed ID: 11171632
[TBL] [Abstract][Full Text] [Related]
13. Gallotannin is a DNA damaging compound that induces senescence independently of p53 and p21 in human colon cancer cells.
Al-Halabi R; Abou Merhi R; Chakilam S; El-Baba C; Hamade E; Di Fazio P; Ocker M; Schneider-Stock R; Gali-Muhtasib H
Mol Carcinog; 2015 Oct; 54(10):1037-50. PubMed ID: 24798519
[TBL] [Abstract][Full Text] [Related]
14. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer.
Mariadason JM; Corner GA; Augenlicht LH
Cancer Res; 2000 Aug; 60(16):4561-72. PubMed ID: 10969808
[TBL] [Abstract][Full Text] [Related]
15. Pleurotus ostreatus inhibits proliferation of human breast and colon cancer cells through p53-dependent as well as p53-independent pathway.
Jedinak A; Sliva D
Int J Oncol; 2008 Dec; 33(6):1307-13. PubMed ID: 19020765
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma.
Lim SC; Choi JE; Kang HS; Han SI
Int J Cancer; 2010 Apr; 126(7):1582-95. PubMed ID: 19728331
[TBL] [Abstract][Full Text] [Related]
17. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells.
Archer SY; Johnson J; Kim HJ; Ma Q; Mou H; Daesety V; Meng S; Hodin RA
Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G696-703. PubMed ID: 16160080
[TBL] [Abstract][Full Text] [Related]
18. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs.
Chang BD; Xuan Y; Broude EV; Zhu H; Schott B; Fang J; Roninson IB
Oncogene; 1999 Aug; 18(34):4808-18. PubMed ID: 10490814
[TBL] [Abstract][Full Text] [Related]
19. Resistance to ursodeoxycholic acid-induced growth arrest can also result in resistance to deoxycholic acid-induced apoptosis and increased tumorgenicity.
Powell AA; Akare S; Qi W; Herzer P; Jean-Louis S; Feldman RA; Martinez JD
BMC Cancer; 2006 Sep; 6():219. PubMed ID: 16948850
[TBL] [Abstract][Full Text] [Related]
20. The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines.
Savickiene J; Borutinskaite VV; Treigyte G; Magnusson KE; Navakauskiene R
Eur J Pharmacol; 2006 Nov; 549(1-3):9-18. PubMed ID: 16978604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
